Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
Ensuring the success of PREDICTOM through effective partnership management
Robin Verjans, Program Manager at Lygature, highlights the importance of effective project management in PREDICTOM which supports the day-to-day work of each partner and ultimately ensures the achievement of PREDICTOM's objectives.
News
''Our models will cover the entire patient's journey: from a patient at home, up to a visit to a healthcare specialist in a memory clinic.''
Holger Fröhlich - Head of AI & Data Science at Fraunhofer SCAI, explains his work on PREDICTOM and sheds light on the data models used in the project as well as the ambitions for wider use of PREDICTOM's data platform.
News
In search for indicators of Alzheimer's disease to detect and track cognitive decline
Spiros Nikolopoulos, Principal Researcher at Centre for Research and Technology Hellas (CERTH), elaborates on his work within PREDICTOM and the importance of finding biomarkers for early detection of Alzheimer's disease. “My motivation has been to help doctors perform their miracles in fighting cognitive decline.”
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.